Aeolus Pharmaceuticals Inc (AOLS)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [OTC US]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [OTC US]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
for [[ item.sessionDateDisplayLong ]]
Fiscal Year End Date: 09/30
| 09-2003 | 06-2003 | 03-2003 | 12-2002 | 09-2002 | |
| Cash Flows From Operating Activities | |||||
| Net Income | -2,970 | -1,904 | -928 | 315 | -11,300 |
| Depreciation Amortization | 160 | 158 | 116 | 67 | 380 |
| Accounts receivable | -64 | N/A | N/A | N/A | 854 |
| Other Working Capital | -1,380 | 276 | -510 | -1,215 | 720 |
| Other Operating Activity | -346 | -1,675 | -1,680 | -1,749 | 796 |
| Operating Cash Flow | $-4,600 | $-3,145 | $-3,002 | $-2,582 | $-8,550 |
| Cash Flows From Investing Activities | |||||
| PPE Investments | 20 | 25 | 2 | 2 | -260 |
| Net Acquisitions | 3,420 | 3,422 | 3,422 | 3,422 | 0 |
| Purchase Of Investment | N/A | N/A | N/A | N/A | -2,013 |
| Other Investing Activity | 0 | 0 | 0 | 0 | 143 |
| Investing Cash Flow | $3,440 | $3,447 | $3,424 | $3,424 | $-2,130 |
| Cash Flows From Financing Activities | |||||
| Change In Short Term Borrowing | 2,020 | N/A | N/A | N/A | 2,578 |
| Debt Repayment | -49 | -49 | -49 | -39 | -25 |
| Common Stock Issued | 2 | N/A | N/A | N/A | 38 |
| Other Financing Activity | -443 | -441 | -441 | -441 | 2,849 |
| Financing Cash Flow | $1,530 | $-490 | $-490 | $-480 | $5,440 |
| Beginning Cash Position | 200 | 209 | 209 | 209 | 5,450 |
| End Cash Position | 580 | 21 | 141 | 571 | 200 |
| Net Cash Flow | $370 | $-188 | $-68 | $362 | $-5,240 |
| Free Cash Flow | |||||
| Operating Cash Flow | -4,600 | -3,145 | -3,002 | -2,582 | -8,550 |
| Capital Expenditure | N/A | N/A | N/A | N/A | -260 |
| Free Cash Flow | -4,600 | -3,145 | -3,002 | -2,582 | -8,810 |